About this trial
This study is to assess the feasibility and acceptability of the PASS in patients with OSA. Second, the study examines its effectiveness in improving PAP uptake and adherence, self-efficacy in self-care, changes in health-related habits, and health outcomes. We also assess the facilitators and barriers to implementing the PASS.
This is a two-group pilot randomized controlled trial (n=60) with a 4-month follow-up. Subjects assigned to the intervention group will receive a 4-month Personalized and Adaptive Sleep Support (PASS) program, a digital platform-based intervention. The 4-month program incorporates: i) a 20-minute brief motivational interviewing session; ii) a digital platform where users can view personalized OSA health-related videos and information, track their adherence to prescribed treatments, log their daily activities and dietary intake, and set personal health goals; and iii) continuous personalized chat-based messaging and phone call support. Participants in the control group will receive a 4-month general hygiene program, including (i) a 20-minute session, (ii) messaging, and (iii) phone call support.
The feasibility and acceptability of the PASS will be evaluated via semi-structured interviews at the 4-month follow-up. Self-administered questionnaires will be used at baseline, 2 months, and 4 months, and objective assessment tools (such as sleep tests) will be used at baseline and at the 2- and 4-month follow-ups. PAP adherence data will be downloaded from PAP machines (if available) for all subjects in both groups at baseline and at month 4.
Eligibility criteria
Qualifiers
Aged 18 years and above
Newly diagnosed with OSA (diagnosis made within the past year)
Newly started or not yet started Positive Airway Pressure (PAP) treatment, with a treatment duration of less than 6 months
Physically inactive (self-reported moderate physical activity per week of <150 minutes)
Disqualifiers
Clinically significant psychiatric disorder
Use of prescription drugs or clinically significant drugs affecting sleep.
Trial design
Treatments tested in this trial
- 4-month Personalized and Adaptive Sleep Support program (PASS)
- Control group
Treatment groups
Locations
Sponsors and collaborators
Hong Kong Metropolitan University
Lead sponsor
Queen Mary Hospital, Hong Kong
Collaborator